REGISTRATION

New Advances in Precision Oncology

  • Blueprint Medicines portfolio update
  • NSCLC treatment landscape and BLU-667 clinical data review

Thank you for your interest in Blueprint Medicines’ upcoming reception from 6-8pm on Monday, June 3.

Please complete the form below to confirm your registration.